Showing results (521-530 of 537) with videos related to
Sort By:
Pageof 54
Blood|May 23, 2018
Tyrosine kinase inhibitor-induced defects in DNA repair sensitize FLT3(ITD)-positive leukemia cells to PARP1 inhibitorsSilvia Maifrede, Margaret Nieborowska-Skorska, Katherine Sullivan-Reed, et al.Genetics|July 7, 2017
Tracing Genetic Exchange and Biogeography of Cryptococcus neoformans var. grubii at the Global Population LevelJohanna Rhodes, Christopher A Desjardins, Sean M Sykes, et al.Nature|July 13, 2022
Structure-function analysis of the SHOC2-MRAS-PP1C holophosphatase complexJason J Kwon, Behnoush Hajian, Yuemin Bian, et al.Physical Review Letters|October 9, 2002
Constraints on cosmological parameters from the analysis of the cosmic lens all sky survey radio-selected gravitational lens statisticsK-H Chae, A D Biggs, R D Blandford, et al.The Journal of Clinical Investigation|May 9, 2017
Gene expression and mutation-guided synthetic lethality eradicates proliferating and quiescent leukemia cellsMargaret Nieborowska-Skorska, Katherine Sullivan, Yashodhara Dasgupta, et al.Mbio|October 14, 2020
From People to Panthera: Natural SARS-CoV-2 Infection in Tigers and Lions at the Bronx ZooDenise McAloose, Melissa Laverack, Leyi Wang, et al.Blood|December 29, 2022
DNA polymerase θ protects leukemia cells from metabolically induced DNA damageUmeshkumar Vekariya, Monika Toma, Margaret Nieborowska-Skorska, et al.Cancer Research|July 3, 2021
TET2 and DNMT3A Mutations Exert Divergent Effects on DNA Repair and Sensitivity of Leukemia Cells to PARP InhibitorsSilvia Maifrede, Bac Viet Le, Margaret Nieborowska-Skorska, et al.Medrxiv : the Preprint Server for Health Sciences|July 17, 2025
Dominant negative ATP5F1A variants disrupt oxidative phosphorylation causing neurological disordersSara M Fielder, Marisa W Friederich, Daniella H Hock, et al.Plastic and Reconstructive Surgery|April 15, 2011
Facial soft-tissue fillers conference: assessing the state of the scienceRod J Rohrich, C William Hanke, Mariano Busso, et al.Pageof 54